Abstract
Ureteral stricture (US), characterized by fibrotic remodeling of the ureteral wall, represents an obstructive urological disorder with incompletely characterized pathophysiological mechanisms. This study integrates single-cell RNA sequencing (scRNA-seq) with immunohistochemical validation in human tissues to investigate the molecular and cellular mechanisms underlying US pathogenesis. In US tissues, we identified significant downregulation of urothelial cell-specific gene signatures and attenuated intercellular crosstalk between urothelial cells and fibroblasts. Specifically, the KLF5-ANXA1-FPR2 signaling axis was identified as a critical homeostatic regulator. Our findings establish that impaired urothelial cell function and disrupted communication are central to fibrotic remodeling, providing novel targets for antifibrotic intervention.
Introduction
Ureteral stricture (US) is a common but complex urological condition where the ureteral wall undergoes pathological fibrotic remodeling. This scarring leads to the narrowing of the lumen, obstructing urine flow and potentially resulting in permanent kidney damage or failure. While US often follows mechanical trauma, kidney stones, or surgical intervention, the underlying cellular and molecular triggers that drive this persistent scarring have remained poorly understood.
Current clinical management, such as the placement of stents or complex reconstructive surgeries, primarily addresses the physical obstruction. However, these interventions often fail because they do not target the biological processes driving the fibrosis. This study aimed to map the transcriptomic landscape of the diseased ureter to identify specific molecular targets that could halt or prevent the fibrotic process.
Methods
The researchers employed a multi-pronged approach to dissect the cellular environment of the ureter:
- Single-cell RNA sequencing (scRNA-seq): A total of 66,031 individual cells were analyzed from 15 human ureter samples (7 stricture, 8 normal controls). This high-resolution approach allowed for the identification of gene expression profiles across 11 major cell types, including urothelial cells, fibroblasts, smooth muscle cells, and immune populations.
- Bioinformatics Pipelines: Tools such as Augur were used to identify the cell types most sensitive to the disease state. CellChat was utilized to map intercellular communication networks, and SCENIC identified key transcription factors regulating these processes.
- Histological and Protein Validation: Findings were validated in human tissue sections using H&E staining, Masson’s trichrome (to visualize collagen deposition), and multi-color immunofluorescence to confirm the presence or absence of key proteins.
Key Insights: The Urothelial-Fibroblast Axis
The study's most significant finding is the identification of a "broken conversation" between the ureter's lining (urothelium) and its structural support cells (fibroblasts).
The Urothelium as a Primary Sensor
Using Augur analysis, the researchers discovered that urothelial cells are the most transcriptomically sensitive to the stricture environment. This suggests that the pathogenesis of US may originate in the urothelium rather than the deeper stromal layers. Furthermore, healthy ureters possess a specific subpopulation of "ROS-responsive" urothelial cells designed to manage oxidative stress. In stricture tissues, this population is significantly depleted, leaving the tissue vulnerable to urine-induced inflammation and oxidative damage.
The KLF5-ANXA1-FPR2 Signaling Pathway
The study identified the KLF5-ANXA1-FPR2 axis as a critical molecular brake on fibrosis. In a healthy state, the transcription factor KLF5 promotes the expression of ANXA1 in urothelial cells. ANXA1 is secreted and acts as a ligand, binding to the FPR2 receptor on nearby fibroblasts. This interaction maintains fibroblast homeostasis, preventing them from transitioning into a pro-fibrotic state. In stricture tissues, this axis is severely disrupted, with massive downregulation of ANXA1 in the urothelium and a corresponding depletion of the FPR2 receptor on fibroblasts.
Fibroblast Heterogeneity
The research identified six distinct fibroblast subtypes. In strictures, there is a shift in the fibroblast landscape: "pro-fibrotic" subtypes (such as Fib-CCL19) increase, while "homeostatic" subtypes (such as Fib-THBS1) are lost. This cellular shift correlates with the increased collagen deposition observed in histological samples.
Results and Clinical Implications
The integration of sequencing and tissue validation confirmed that stricture regions exhibit a significant decrease in urothelial cells and a marked increase in fibroblasts and immune cells (specifically B cells and NKT cells). Immunofluorescence confirmed the depletion of KLF5, ANXA1, and FPR2 in diseased tissue, providing a clear molecular signature for US.
These findings suggest that the ANXA1-FPR2 interaction is essential for maintaining ureteral health. Clinically, this opens the door for novel therapeutic strategies. For example, synthetic FPR2 agonists or drug-eluting stents designed to mimic the ANXA1 signal could potentially prevent the development of strictures after surgery or trauma.
Limitations and Future Directions
While the study provides a high-resolution map of US, several areas require further exploration. Functional studies (in vitro or in vivo) are needed to prove that restoring the ANXA1-FPR2 signal can reverse or prevent fibrosis. Additionally, future studies should include larger cohorts to determine if these molecular signatures vary based on the etiology of the stricture (e.g., radiation-induced vs. post-surgical). Transitioning from a molecular target to a clinical therapy remains a long-term goal that requires extensive pharmacological testing.
Summary updated